Fiber tracts anomalies in APPxPS1 transgenic mice modeling alzheimer's disease

Journal of Aging Research

Volumn 2011, Issue , 2011, Pages

  Chen, H ^a,b   Epelbaum, S ^c   Delatour, B ^a,c  

^a CNRS   (France)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MYELIN;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR COMMISSURE; ARTICLE; CELL DEGENERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE SEVERITY; FEMALE; FIBER TRACT ANOMALY; FOREBRAIN; MOUSE; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SYMPTOM; TRANSGENIC MOUSE;

EID: 84869470927     PISSN: 20902204     EISSN: 20902212     Source Type: Journal    
DOI: 10.4061/2011/281274     Document Type: Article

References (80)

1. Hardy J. A., Higgins G. A., Alzheimer's disease: the amyloid cascade hypothesis. Science 1992 256 5054 184 185 2-s2.0-0026597063
2. Sommer B., Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Current Opinion in Pharmacology 2002 2 1 87 92 2-s2.0-0036462453 10.1016/S1471-4892(01)00126-6
3. Duyckaerts C., Potier M. C., Delatour B., Alzheimer disease models and human neuropathology: similarities and differences. Acta Neuropathologica 2008 115 1 5 38 2-s2.0-36949016215 10.1007/s00401-007-0312-8 (Pubitemid 50005258)
4. Games D., Buttini M., Kobayashi D., Schenk D., Seubert P., Mice as models: transgenic approaches and Alzheimer's disease. Journal of Alzheimer's Disease 2006 9 3, supplement 133 149 2-s2.0-33747487095 (Pubitemid 44255487)
5. Higgins G. A., Jacobsen H., Transgenic mouse models of Alzheimer's disease: phenotype and application. Behavioural Pharmacology 2003 14 5-6 419 438 2-s2.0-0141596079 (Pubitemid 37176800)
6. Chen G., Chen K. S., Knox J., Inglis J., Bernard A., Martin S. J., Justice A., McConlogue L., Games D., Freedman S. B., Morris R. G. M., A learning deficit related to age and β -amyloid plaques in a mouse model of alzheimer's disease. Nature 2000 408 6815 975 979 2-s2.0-0034700480 10.1038/35050103 (Pubitemid 32101643)
7. Cummings B. J., Pike C. J., Shankle R., Cotman C. W., β -amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiology of Aging 1996 17 6 921 933 2-s2.0-0030464914 10.1016/S0197-4580(96)00170-4 (Pubitemid 27022746)
8. Holmes C., Boche D., Wilkinson D., Yadegarfar G., Hopkins V., Bayer A., Jones R. W., Bullock R., Love S., Neal J. W., Zotova E., Nicoll J. A., Long-term effects of A β 42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. The Lancet 2008 372 9634 216 223 2-s2.0-47149112621 10.1016/S0140-6736(08)61075-2 (Pubitemid 351978111)
9. King D. L., Arendash G. W., Crawford F., Sterk T., Menendez J., Mullan M. J., Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behavioural Brain Research 1999 103 2 145 162 2-s2.0-0033199822 10.1016/S0166-4328(99)00037-6 (Pubitemid 29417998)
10. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A., Katzman R., Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Annals of Neurology 1991 30 4 572 580 2-s2.0-0025987048 10.1002/ana.410300410
11. Walsh D. M., Selkoe D. J., A β oligomers-a decade of discovery. Journal of Neurochemistry 2007 101 5 1172 1184 2-s2.0-34248190279 10.1111/j.1471-4159.2006.04426.x (Pubitemid 46718812)
12. Shankar G. M., Li S., Mehta T. H., Garcia-Munoz A., Shepardson N. E., Smith I., Brett F. M., Farrell M. A., Rowan M. J., Lemere C. A., Regan C. M., Walsh D. M., Sabatini B. L., Selkoe D. J., Amyloid- β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine 2008 14 8 837 842 2-s2.0-49149124343 10.1038/nm1782
13. Brun A., Englund E., A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Annals of Neurology 1986 19 3 253 262 2-s2.0-0022572209 (Pubitemid 16111074)
14. Gonzalez-Lima F., Berndt J. D., Valla J. E., Games D., Reiman E. M., Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease. NeuroReport 2001 12 11 2375 2379 2-s2.0-0035828139 (Pubitemid 32684580)
15. Rose S. E., Chen F., Chalk J. B., Zelaya F. O., Strugnell W. E., Benson M., Semple J., Doddrell D. M., Loss of connectivity in Alzheimer's disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. Journal of Neurology Neurosurgery and Psychiatry 2000 69 4 528 530 2-s2.0-0033798013 10.1136/jnnp.69.4.528
16. Song S. K., Kim J. H., Lin S. J., Brendza R. P., Holtzman D. M., Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiology of Disease 2004 15 3 640 647 2-s2.0-1842588702 10.1016/j.nbd.2003.12.003 (Pubitemid 38435343)
17. Nakata Y., Sato N., Nemoto K., Abe O., Shikakura S., Arima K., Furuta N., Uno M., Hirai S., Masutani Y., Ohtomo K., Barkovich A. J., Aoki S., Diffusion abnormality in the posterior cingulum and hippocampal volume: correlation with disease progression in Alzheimer's disease. Magnetic Resonance Imaging 2009 27 3 347 354 2-s2.0-61649126837 10.1016/j.mri.2008.07.013
18. Smith C. D., Chebrolu H., Andersen A. H., Powell D. A., Lovell M. A., Xiong S., Gold B. T., White matter diffusion alterations in normal women at risk of Alzheimer's disease. Neurobiology of Aging 2010 31 7 1122 1131 2-s2.0-77952879133 10.1016/j.neurobiolaging.2008.08.006
19. Di Paola M., Di Iulio F., Cherubini A., Blundo C., Casini A. R., Sancesario G., Passafiume D., Caltagirone C., Spalletta G., When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology 2010 74 14 1136 1142 2-s2.0-77950980521 10.1212/WNL.0b013e3181d7d8cb
20. Thomann P. A., Wüstenberg T., Pantel J., Essig M., Schröder J., Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2006 21 4 215 220 2-s2.0-33645725856 10.1159/000090971
21. Teipel S. J., Bayer W., Alexander G. E., Bokde A. L. W., Zebuhr Y., Teichberg D., Müller-Spahn F., Schapiro M. B., Möller H. J., Rapoport S. I., Hampel H., Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiology of Aging 2003 24 1 85 94 2-s2.0-0037213402 10.1016/S0197-4580(02)00044-1 (Pubitemid 35454146)
22. Villain N., Desgranges B., Viader F., De La Sayette V., Mézenge F., Landeau B., Baron J. C., Eustache F., Chételat G., Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. Journal of Neuroscience 2008 28 24 6174 6181 2-s2.0-46749141280 10.1523/JNEUROSCI.1392-08.2008
23. Bartzokis G., Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiology of Aging 2004 25 1 5 18 2-s2.0-0346770038 10.1016/j.neurobiolaging.2003.03.001 (Pubitemid 37522186)
24. Bartzokis G., Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders. Neurobiology of Aging 2004 25 1 49 62 2-s2.0-0346220384 10.1016/j.neurobiolaging.2003.08.001 (Pubitemid 37522193)
25. Benes F. M., Farol P. A., Majocha R. E., Marotta C. A., Bird E. D., Evidence for axonal loss in regions occupied by senile plaques in Alzheimer cortex. Neuroscience 1991 42 3 651 660 2-s2.0-0025761248 10.1016/0306-4522(91) 90034-L
26. Delatour B., Blanchard V., Pradier L., Duyckaerts C., Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiology of Disease 2004 16 1 41 47 2-s2.0-2342653632 10.1016/j.nbd.2004.01.008 (Pubitemid 38569794)
27. Jantaratnotai N., Ryu J. K., Kim S. U., McLarnon J. G., Amyloid β peptide-induced corpus callosum damage and glial activation in vivo. NeuroReport 2003 14 11 1429 1433 2-s2.0-0041330612 10.1097/00001756-200308060-00005 (Pubitemid 37083122)
28. Phinney A. L., Deller T., Stalder M., Calhoun M. E., Frotscher M., Sommer B., Staufenbiel M., Jucker M., Cerebral amyloid induces aberrant axonal sprouting and ectopic terminal formation in amyloid precursor protein transgenic mice. Journal of Neuroscience 1999 19 19 8552 8559 2-s2.0-0033215972 (Pubitemid 30226773)
29. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T. A., Langui D., Duyckaerts C., Tremp G., Pradier L., Time sequence of maturation of dystrophic neurites associated with A β deposits in APP/PS1 transgenic mice. Experimental Neurology 2003 184 1 247 263 2-s2.0-0344826476 10.1016/S0014-4886(03)00252-8 (Pubitemid 37444035)
30. Delatour B., Guégan M., Volk A., Dhenain M., In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiology of Aging 2006 27 6 835 847 2-s2.0-33646173272 10.1016/j. neurobiolaging.2005.04.011
31. Wirths O., Weis J., Szczygielski J., Multhaup G., Bayer T. A., Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Acta Neuropathologica 2006 111 4 312 319 2-s2.0-33645764470 10.1007/s00401-006-0041-4
32. Moon W. J., Kim H. J., Roh H. G., Han S. H., Atrophy measurement of the anterior commissure and substantia innominata with 3T high-resolution MR imaging: does the measurement differ for patients with frontotemporal lobar degeneration and Alzheimer disease and for healthy subjects? American Journal of Neuroradiology 2008 29 7 1308 1313 2-s2.0-49749118669 10.3174/ajnr.A1103
33. Teipel S. J., Bayer W., Alexander G. E., Zebuhr Y., Teichberg D., Kulic L., Schapiro M. B., Möller H. J., Rapoport S. I., Hampel H., Progression of corpus callosum atrophy in Alzheimer disease. Archives of Neurology 2002 59 2 243 248 2-s2.0-0036129788 (Pubitemid 34240940)
34. Schmued L. C., A rapid, sensitive histochemical stain for myelin in frozen brain sections. Journal of Histochemistry and Cytochemistry 1990 38 5 717 720 2-s2.0-0025259466 (Pubitemid 20146217)
35. Wahlsten D., Colbourne F., Pleus R., A robust, efficient and flexible method for staining myelinated axons in blocks of brain tissue. Journal of Neuroscience Methods 2003 123 2 207 214 2-s2.0-0037445483 10.1016/S0165-0270(02) 00359-X (Pubitemid 36279415)
36. Desai M. K., Mastrangelo M. A., Ryan D. A., Sudol K. L., Narrow W. C., Bowers W. J., Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. American Journal of Pathology 2010 177 3 1422 1435 2-s2.0-77956502794 10.2353/ajpath.2010.100087
37. Schmitz C., Rutten B. P. F., Pielen A., Schäfer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H. W. M., Pradier L., Bayer T. A., Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. American Journal of Pathology 2004 164 4 1495 1502 2-s2.0-12144288683 (Pubitemid 38387814)
38. Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K., Bayer T. A., Intraneuronal A β accumulation precedes plaque formation in β -amyloid precursor protein and presenilin-1 double-transgenic mice. Neuroscience Letters 2001 306 1-2 116 120 2-s2.0-0035933279 10.1016/S0304-3940(01)01876-6 (Pubitemid 32524311)
39. Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K., Bayer T. A., Reelin in plaques of β -amyloid precursor protein and presenilin-1 double-transgenic mice. Neuroscience Letters 2001 316 3 145 148 2-s2.0-0035966144 10.1016/S0304-3940(01)02399-0 (Pubitemid 34020750)
40. Puchtler H., Sweat F., Levine M., On the binding of Congo red by amyloid. Journal of Histochemistry and Cytochemistry 1962 10 355 364
41. Christensen D. Z., Kraus S. L., Flohr A., Cotel M. C., Wirths O., Bayer T. A., Transient intraneuronal A β rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Acta Neuropathologica 2008 116 6 647 655 2-s2.0-56749152364 10.1007/s00401-008- 0451-6
42. Schmued L. C., Hopkins K. J., Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Research 2000 874 2 123 130 2-s2.0-0034714392 10.1016/S0006-8993(00)02513-0
43. Savaskan N. E., Eyüpoglu I. Y., Bräuer A. U., Plaschke M., Ninnemann O., Nitsch R., Skutella T., Entorhinal cortex lesion studied with the novel dye Fluoro-Jade. Brain Research 2000 864 1 44 51 2-s2.0-0034607571 10.1016/S0006-8993(00)02148-X (Pubitemid 30227596)
44. Hamano K., Iwasaki N., Takeya T., Takita H., A quantitative analysis of rat central nervous system myelination using the immunohistochemical method for MBP. Developmental Brain Research 1996 93 1-2 18 22 2-s2.0-0029977890
45. Paxinos G., Franklin K. B. J., The Mouse Brain in Stereotaxic Coordinates 2001 2nd San Diego, Calif, USA Academic Press
46. Le Cudennec C., Faure A., Ly M., Delatour B., One-year longitudinal evaluation of sensorimotor functions in APP 751SL transgenic mice. Genes, Brain and Behavior 2008 7 supplement 1 83 91 2-s2.0-37749039886 10.1111/j.1601-183X. 2007.00374.x
47. Delatour B., Blanchard V., Pradier L., Duyckaerts C., Alzheimer pathology disorganizes cortico-cortical circuitry: direct evidence from a transgenic animal model. Neurobiology of Disease 2004 16 1 41 47 2-s2.0-2342653632 10.1016/j.nbd.2004.01.008 (Pubitemid 38569794)
48. Delatour B., Witter M. P., Projections from the parahippocampal region to the prefrontal cortex in the rat: evidence of multiple pathways. European Journal of Neuroscience 2002 15 8 1400 1407 2-s2.0-0036460278 10.1046/j.1460-9568.2002.01973.x (Pubitemid 35478002)
49. ® B staining as useful tool to identify activated microglia and astrocytes in a mouse transgenic model of Alzheimer's disease. Brain Research 2007 1128 1 40 49 2-s2.0-33846019228 10.1016/j.brainres.2006.05.050 (Pubitemid 46048621)
50. Dhenain M., El Tayara N. T., Wu T. D., Guégan M., Volk A., Quintana C., Delatour B., Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiology of Aging 2009 30 1 41 53 2-s2.0-56249116571 10.1016/j.neurobiolaging.2007.05.018
51. Gouw A. A., Seewann A., Vrenken H., van der Flier W. M., Rozemuller J. M., Barkhof F., Scheltens P., Geurts J. J. G., Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008 131 12 3286 3298 2-s2.0-58149125355 10.1093/brain/awn265
52. Marner L., Nyengaard J. R., Tang Y., Pakkenberg B., Marked loss of myelinated nerve fibers in the human brain with age. Journal of Comparative Neurology 2003 462 2 144 152 2-s2.0-0038467307 10.1002/cne.10714 (Pubitemid 36723664)
53. Desai M. K., Sudol K. L., Janelsins M. C., Mastrangelo M. A., Frazer M. E., Bowers W. J., Triple-transgenic Alzheimer's disease mice exhibit region-specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology. GLIA 2009 57 1 54 65 2-s2.0-61449120013 10.1002/glia.20734
54. Mitew S., Kirkcaldie M. T. K., Halliday G. M., Shepherd C. E., Vickers J. C., Dickson T. C., Focal demyelination in Alzheimer's disease and transgenic mouse models. Acta Neuropathologica 2010 119 5 567 577 2-s2.0-77953022585 10.1007/s00401-010-0657-2
55. Redwine J. M., Kosofsky B., Jacobs R. E., Games D., Reilly J. F., Morrison J. H., Young W. G., Bloom F. E., Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1381 1386 2-s2.0-0037417899 10.1073/pnas.242746599 (Pubitemid 36184010)
56. Chaim T. M., Duran F. L. S., Uchida R. R., Périco C. A. M., de Castro C. C., Busatto G. F., Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry. Psychiatry Research 2007 154 1 59 68 2-s2.0-33846069575 10.1016/j.pscychresns.2006.04.003 (Pubitemid 46072704)
57. Parhad I. M., Scott J. N., Cellars L. A., Bains J. S., Krekoski C. A., Clark A. W., Axonal atrophy in aging is associated with a decline in neurofilament gene expression. Journal of Neuroscience Research 1995 41 3 355 366 2-s2.0-0029008671 10.1002/jnr.490410308
58. Bartzokis G., Lu P. H., Mintz J., Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimer's and Dementia 2007 3 2 122 125 2-s2.0-34247198450 10.1016/j.jalz.2007.01.019 (Pubitemid 46613474)
59. Hamano K., Takeya T., Iwasaki N., Nakayama J., Ohto T., Okada Y., A quantitative study of the progress of myelination in the rat central nervous system, using the immunohistochemical method for proteolipid protein. Developmental Brain Research 1998 108 1-2 287 293 2-s2.0-0032527033 10.1016/S0165-3806(98)00063-7 (Pubitemid 28332839)
60. Braak H., Braak E., Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathologica 1996 92 2 197 201 2-s2.0-0029967367 10.1007/s004010050508 (Pubitemid 26248463)
61. Stricker N. H., Schweinsburg B. C., Delano-Wood L., Wierenga C. E., Bangen K. J., Haaland K. Y., Frank L. R., Salmon D. P., Bondi M. W., Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis. NeuroImage 2009 45 1 10 16 2-s2.0-60149083951 10.1016/j.neuroimage.2008.11.027
62. Katz M. J., Lasek R. J., Silver J., Ontophylectics of the nervous system: development of the corpus callosum and evolution of axon tracts. Proceedings of the National Academy of Sciences of the United States of America 1983 80 19 5936 5940 2-s2.0-0020842115 (Pubitemid 14227587)
63. Power J., Mayer-Pröschel M., Smith J., Noble M., Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions. Developmental Biology 2002 245 2 362 375 2-s2.0-0037093112 10.1006/dbio.2002. 0610 (Pubitemid 34521608)
64. Xu J., Chen S., Ahmed S. H., Chen H., Ku G., Goldberg M. P., Hsu C. Y., Amyloid-beta peptides are cytotoxic to oligodendrocytes. The Journal of Neuroscience 2001 21 1 RC118 2-s2.0-0035227685
65. El Tayara N. T., Delatour B., Volk A., Dhenain M., Detection of vascular alterations by in vivo magnetic resonance angiography and histology in APP/PS1 mouse model of Alzheimer's disease. Magnetic Resonance Materials in Physics, Biology and Medicine 2010 23 1 53 64 2-s2.0-76649137234 10.1007/s10334-009-0194- y
66. Gouw A. A., aa.gouw@vumc.nl Seewann A., van der Flier W. M., Barkhof F., Rozemuller A. M., Scheltens P., Geurts J. J.G., Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. Journal of Neurology, Neurosurgery and Psychiatry 2011 82 2 126 135 10.1136/jnnp.2009. 204685
67. Hatanpää K., Isaacs K. R., Shirao T., Brady D. R., Rapoport S. I., Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. Journal of Neuropathology and Experimental Neurology 1999 58 6 637 643 (Pubitemid 29264943)
68. Armstrong R. A., Syed A. B., Smith C. U. M., Density and cross-sectional areas of axons in the olfactory tract in control subjects and Alzheimer's disease: an image analysis study. Neurological Sciences 2008 29 1 23 27 2-s2.0-44449136135 10.1007/s10072-008-0854-0
69. Bussière T., Giannakopoulos P., Bouras C., Perl D. P., Morrison J. H., Hof P. R., Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9. Journal of Comparative Neurology 2003 463 3 281 302 2-s2.0-0037480114 10.1002/cne.10760 (Pubitemid 36842397)
70. Ramos B., Baglietto-Vargas D., Rio J. C. D., Moreno-Gonzalez I., Santa-Maria C., Jimenez S., Caballero C., Lopez-Tellez J. F., Khan Z. U., Ruano D., Gutierrez A., Vitorica J., Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiology of Aging 2006 27 11 1658 1672 2-s2.0-33748565334 10.1016/j.neurobiolaging.2005.09.022 (Pubitemid 44363105)
71. Casas C., Sergeant N., Itier J. M., Blanchard V., Wirths O., van der Kolk N., Vingtdeux V., van de Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T. A., Benoit P., Pradier L., Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated A β 42 accumulation in a novel Alzheimer transgenic model. American Journal of Pathology 2004 165 4 1289 1300 2-s2.0-4644276796 (Pubitemid 39297734)
72. Stokin G. B., Almenar-Queralt A., Gunawardena S., Rodrigues E. M., Falzone T., Kim J., Lillo C., Mount S. L., Roberts E. A., McGowan E., Williams D. S., Goldstein L. S. B., Amyloid precursor protein-induced axonopathies are independent of amyloid- β peptides. Human Molecular Genetics 2008 17 22 3474 3486 2-s2.0-54949151536 10.1093/hmg/ddn240
73. Echeverria V., Cuello A. C., Intracellular A-beta amyloid, a sign for worse things to come? Molecular Neurobiology 2002 26 2-3 299 316 2-s2.0-0036772311 10.1385/MN:26:2-3:299 (Pubitemid 35239806)
74. LaFerla F. M., Green K. N., Oddo S., Intracellular amyloid- β in Alzheimer's disease. Nature Reviews Neuroscience 2007 8 7 499 509 2-s2.0-34250819839 10.1038/nrn2168 (Pubitemid 46985362)
75. Langui D., Girardot N., El Hachimi K. H., Allinquant B., Blanchard V., Pradier L., Duyckaerts C., Subcellular topography of neuronal A β peptide in APPxPS1 transgenic mice. American Journal of Pathology 2004 165 5 1465 1477 2-s2.0-7244234180 (Pubitemid 39435147)
76. Aboitiz F., Scheibel A. B., Fisher R. S., Zaidel E., Fiber composition of the human corpus callosum. Brain Research 1992 598 1-2 143 153 2-s2.0-0027097055 10.1016/0006-8993(92)90178-C (Pubitemid 23013055)
77. Innocenti G., Jones E., Peters A., General organization of callosal connections in the cerebral cortex. Cerebral Cortex 1986 New York, NY, USA Plenum Press 291 353
78. Jones E., Peters A., Jones E., Laminar distribution of cortical efferent cells. Cerebral Cortex 1984 New York, NY, USA Plenum Press 521 553
79. Yorke C. H. Jr., Caviness V. S. Jr., Interhemispheric neocortical connections of the corpus callosum in the normal mouse: a study based on anterograde and retrograde methods. Journal of Comparative Neurology 1975 164 2 233 245 2-s2.0-0016827911
80. Pigino G., Morfini G., Atagi Y., Deshpande A., Yu C., Jungbauer L., LaDu M., Busciglio J., Brady S., Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proceedings of the National Academy of Sciences of the United States of America 2009 106 14 5907 5912 2-s2.0-65249161745 10.1073/pnas.0901229106